Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity
-
Davide Sartini
, Riccardo Seta
Abstract
Lung cancer is the second most commonly diagnosed neoplasm, and represents the leading cause of tumour death worldwide. As patients are often diagnosed at a late stage, current therapeutic strategies have limited effectiveness and the prognosis remains poor. Successful treatment depends on early diagnosis and knowledge concerning molecular mechanisms underlying lung carcinogenesis. In the present study, we focused on nicotinamide N-methyltransferase (NNMT), which is overexpressed in several malignancies. First, we analysed NNMT expression in a cohort of 36 patients with non-small cell lung cancer (NSCLC) by immunohistochemistry. Subsequently, we examined NNMT expression levels in the human lung cancer cell line A549 by Real-Time PCR, Western blot and catalytic activity assay, and evaluated the effect of NNMT knockdown on cell proliferation and anchorage-independent cell growth by MTT and soft agar colony formation assays, respectively. NSCLC displayed higher NNMT expression levels compared to both tumour-adjacent and surrounding tissue. Moreover, shRNA-mediated gene silencing of NNMT led to a significant inhibition of cell proliferation and colony formation ability on soft agar. Our results show that the downregulation of NNMT significantly reduced in vitro tumorigenicity of A549 cells and suggest that NNMT could represent an interesting molecular target for lung cancer therapy.
References
Aksoy, S., Szumlanski, C.L., and Weinshilboum, R.M. (1994). Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J. Biol. Chem. 269, 14835–14840.10.1016/S0021-9258(17)36700-5Search in Google Scholar
Audrito, V., Vaisitti, T., Rossi, D., Gottardi, D., D’Arena, G., Laurenti, L., Gaidano, G., Malavasi, F., and Deaglio, S. (2011). Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res. 71, 4473–4483.10.1158/0008-5472.CAN-10-4452Search in Google Scholar
Balducci, E., Emanuelli, M., Raffaelli, N., Ruggieri, S., Amici, A., Magni, G., Orsomando, G., Polzonetti, V., and Natalini, P. (1995). Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal. Biochem. 228, 64–68.10.1006/abio.1995.1315Search in Google Scholar
Bartuś, M., Łomnicka, M., Kostogrys, R.B., Kaźmierczak, P., Watała, C., Słominska, E.M., Smoleński, R.T., Pisulewski, P.M., Adamus, J., Gebicki, J., et al. (2008). 1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats. Pharmacol. Rep. 60, 127–138.Search in Google Scholar
Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.10.1016/0003-2697(76)90527-3Search in Google Scholar
Brzozowski, T., Konturek, P.C., Chlopicki, S., Sliwowski, Z., Pawlik, M., Ptak-Belowska, A., Kwiecien, S., Drozdowicz, D., Pajdo, R., Slonimska, E., et al. (2008). Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves. J. Pharmacol. Exp. Ther. 326, 105–116.10.1124/jpet.108.136457Search in Google Scholar PubMed
Chlopicki, S., Swies, J., Mogielnicki, A., Buczko, W., Bartus, M., Lomnicka, M., Adamus, J., and Gebicki, J. (2007). 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br. J. Pharmacol. 152, 230–239.10.1038/sj.bjp.0707383Search in Google Scholar PubMed PubMed Central
D’Andrea, F.P., Safwat, A., Kassem, M., Gautier, L., Overgaard, J., and Horsman, M.R. (2011). Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiother. Oncol. 99, 373–378.10.1016/j.radonc.2011.05.086Search in Google Scholar PubMed
Debigaré, R., Maltais, F., Côté, C.H., Michaud, A., Caron, M.A., Mofarrahi, M., Leblanc, P., and Hussain, S.N. (2008). Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting. COPD. 5, 75–84.10.1080/15412550801940457Search in Google Scholar PubMed
Emanuelli, M., Santarelli, A., Sartini, D., Ciavarella, D., Rossi, V., Pozzi, V., Rubini, C., and Lo Muzio, L. (2010). Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma. Histol. Histopathol. 25, 15–20.Search in Google Scholar
Kim, H.C., Mofarrahi, M., Vassilakopoulos, T., Maltais, F., Sigala, I., Debigare, R., Bellenis, I., and Hussain, S.N. (2010). Expression and functional significance of nicotinamide N-methyl transferase in skeletal muscles of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 181, 797–805.10.1164/rccm.200906-0936OCSearch in Google Scholar PubMed
Lim, B.H., Cho, B.I., Kim, Y.N., Kim, J.W., Park, S.T., and Lee, C.W. (2006). Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp. Mol. Med. 38, 455–465.10.1038/emm.2006.54Search in Google Scholar PubMed
Liu, Y., He, S., Ding, Y., Huang, J., Zhang, Y., and Chen, L. (2014). The efficacy and safety of thalidomide-based therapy in patients with advanced non-small cell lung cancer: a meta-analysis. Contemp. Oncol. 18, 39–47.10.5114/wo.2014.40782Search in Google Scholar
Markert, J.M., Fuller, C.M., Gillespie, G.Y., Bubien, J.K., McLean, L.A., Hong, R.L., Lee, K., Gullans, S.R., Mapstone, T.B., and Benos, D.J. (2001). Differential gene expression profiling in human brain tumors. Physiol. Genomics. 5, 21–33.10.1152/physiolgenomics.2001.5.1.21Search in Google Scholar
Mateuszuk, Ł., Khomich, T.I., Słomińska, E., Gajda, M., Wójcik, L., łomnicka, M., Gwóźdź, P., and Chłopicki, S. (2009). Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis. Pharmacol. Rep. 61, 76–85.10.1016/S1734-1140(09)70009-XSearch in Google Scholar
Milani, Z.H., Ramsden, D.B., and Parsons, R.B. (2013). Neuroprotective effects of nicotinamide N-methyltransferase and its metabolite 1-methylnicotinamide. J. Biochem. Mol. Toxicol. 27, 451–456.10.1002/jbt.21508Search in Google Scholar
Niklinski, J. and Hirsch, F.R. (2002). Molecular approaches to lung cancer evaluation. Lung Cancer. 38, S9–S17.10.1016/S0169-5002(02)00260-XSearch in Google Scholar
Parsons, R.B., Smith, M.L., Williams, A.C., Waring, R.H., and Ramsden, D.B. (2002). Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain. J. Neuropathol. Exp. Neurol. 61, 111–124.10.1093/jnen/61.2.111Search in Google Scholar PubMed
Parsons, R.B., Aravindan, S., Kadampeswaran, A., Evans, E.A., Sandhu, K.K., Levy, E.R., Thomas, M.G., Austen, B.M., and Ramsden, D.B. (2011). The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors. Biochem. J. 436, 145–155.10.1042/BJ20101685Search in Google Scholar PubMed
Pei, B.X., Sun, B.S., Zhang, Z.F., Wang, A.L., and Ren, P. (2014). Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. In press.10.1016/j.jtcvs.2014.05.003Search in Google Scholar PubMed
Peng, Y., Sartini, D., Pozzi, V., Wilk, D., Emanuelli, M., and Yee, V.C. (2011). Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry. 50, 7800–7808.10.1021/bi2007614Search in Google Scholar PubMed PubMed Central
Pozzi, V., Mazzotta, M., Lo Muzio, L., Sartini, D., Santarelli, A., Renzi, E., Rocchetti, R., Tomasetti, M., Ciavarella, D., and Emanuelli, M. (2011). Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. Int. J. Immunopathol. Pharmacol. 24, 69–77.10.1177/039463201102400109Search in Google Scholar PubMed
Pozzi, V., Sartini, D., Morganti, S., Giuliante, R., Di Ruscio, G., Santarelli, A., Rocchetti, R., Rubini, C., Tomasetti, M., Giannatempo, G., et al. (2013). RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. PLoS One. 8, e71272.10.1371/journal.pone.0071272Search in Google Scholar
Roessler, M., Rollinger, W., Palme, S., Hagmann, M.L., Berndt, P., Engel, A.M., Schneidinger, B., Pfeffer, M., Andres, H., Karl, J., et al. (2005). Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin. Cancer Res. 11, 6550–6557.10.1158/1078-0432.CCR-05-0983Search in Google Scholar
Rogers, C.D., Fukushima, N., Sato, N., Shi, C., Prasad, N., Hustinx, S.R., Matsubayashi, H., Canto, M., Eshleman, J.R., Hruban, R.H., et al. (2006). Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs. Cancer. Biol. Ther. 5, 1383–1389.10.4161/cbt.5.10.3323Search in Google Scholar
Sartini, D., Muzzonigro, G., Milanese, G., Pierella, F., Rossi, V., and Emanuelli, M. (2006). Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma. J. Urol. 176, 2248–2254.10.1016/j.juro.2006.07.046Search in Google Scholar
Sartini, D., Santarelli, A., Rossi, V., Goteri, G., Rubini, C., Ciavarella, D., Lo Muzio, L., and Emanuelli, M. (2007). Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol. Med. 13, 415–421.10.2119/2007-00035.SartiniSearch in Google Scholar
Sartini, D., Pozzi, V., Renzi, E., Morganti, S., Rocchetti, R., Rubini, C., Santarelli, A., Lo Muzio, L., and Emanuelli, M. (2012). Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. Biol. Chem. 393, 505–11.10.1515/hsz-2012-0112Search in Google Scholar
Sartini, D., Muzzonigro, G., Milanese, G., Pozzi, V., Vici, A., Morganti, S., Rossi, V., Mazzucchelli, R., Montironi, R., and Emanuelli, M. (2013a). Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test. Cell Biochem. Biophys. 65, 473–483.10.1007/s12013-012-9451-1Search in Google Scholar
Sartini, D., Morganti, S., Guidi, E., Rubini, C., Zizzi, A., Giuliante, R., Pozzi, V., and Emanuelli, M. (2013b). Nicotinamide N-methyltransferase in non-small cell lung cancer: promising results for targeted anti-cancer therapy. Cell Biochem. Biophys. 67, 865–873.10.1007/s12013-013-9574-zSearch in Google Scholar
Sternak, M., Khomich, T.I., Jakubowski, A., Szafarz, M., Szczepański, W., Białas, M., Stojak, M., Szymura-Oleksiak, J., and Chłopicki, S. (2010). Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse. Pharmacol. Rep. 62, 483–493.10.1016/S1734-1140(10)70304-2Search in Google Scholar
Sun, S., Schiller, J.H., Spinola, M., and Minna, J.D. (2007). New molecularly targeted therapies for lung cancer. J. Clin. Invest. 117, 2740–2750.10.1172/JCI31809Search in Google Scholar PubMed PubMed Central
Tang, S.W., Yang, T.C., Lin, W.C., Chang, W.H., Wang, C.C., Lai, M.K., and Lin, J.Y. (2011). Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis. 32, 138–145.10.1093/carcin/bgq225Search in Google Scholar PubMed
Ulanovskaya O.A., Zuhl A.M., and Cravatt B.F. (2013). NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat. Chem. Biol. 9, 300–306.10.1038/nchembio.1204Search in Google Scholar PubMed PubMed Central
Wu, Y., Siadaty, M.S., Berens, M.E., Hampton, G.M., and Theodorescu, D. (2008). Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene. 27, 6679–6689.10.1038/onc.2008.264Search in Google Scholar PubMed PubMed Central
Xu, J., Moatamed, F., Caldwell, J.S., Walker, J.R., Kraiem, Z., Taki, K., Brent, G.A., and Hershman, J.M. (2003). Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. J. Clin. Endocrinol. Metab. 88, 4990–4996.10.1210/jc.2002-021843Search in Google Scholar PubMed
Zhang, J. (2003). Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? Bioessays. 25, 808–814.Search in Google Scholar
Zhang, J., Wang, Y., Li, G., Yu, H., and Xie, X. (2014a). Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway. PLoS One. 9, e89202.10.1371/journal.pone.0089202Search in Google Scholar PubMed PubMed Central
Zhang, E.B., Yin, D.D., Sun, M., Kong, R., Liu, X.H., You, L.H., Han, L., Xia, R., Wang, K.M., Yang, J.S., et al. (2014b). P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 22, e1243.10.1038/cddis.2014.201Search in Google Scholar PubMed PubMed Central
Zhao, D.P., Yang, C.L., Zhou, X., Ding, J.A., and Jiang, G.N. (2014). Association between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case-control studies. Mol. Genet. Genomics. In press.10.1007/s00438-014-0868-7Search in Google Scholar PubMed
©2015 by De Gruyter
Articles in the same Issue
- Frontmatter
- Reviews
- The emerging role of the peptidome in biomarker discovery and degradome profiling
- Inflammatory caspases: key regulators of inflammation and cell death
- Minireview
- The role of serpins in tumor cell migration
- Research Articles/Short Communications
- Protein Structure and Function
- A core domain of the BMP2 proregion is sufficient for the biogenesis of mature homodimeric growth factor
- Molecular Medicine
- Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity
- Cell Biology and Signaling
- miR-103 promotes 3T3-L1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D
- miR-126 modulates angiogenic growth parameters of peripheral blood endothelial progenitor cells
- Osteoblastic alkaline phosphatase mRNA is stabilized by binding to vimentin intermediary filaments
- Proteolysis
- Mirolase, a novel subtilisin-like serine protease from the periodontopathogen Tannerella forsythia
- Cathepsin B-deficient mice as source of monoclonal anti-cathepsin B antibodies
Articles in the same Issue
- Frontmatter
- Reviews
- The emerging role of the peptidome in biomarker discovery and degradome profiling
- Inflammatory caspases: key regulators of inflammation and cell death
- Minireview
- The role of serpins in tumor cell migration
- Research Articles/Short Communications
- Protein Structure and Function
- A core domain of the BMP2 proregion is sufficient for the biogenesis of mature homodimeric growth factor
- Molecular Medicine
- Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity
- Cell Biology and Signaling
- miR-103 promotes 3T3-L1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D
- miR-126 modulates angiogenic growth parameters of peripheral blood endothelial progenitor cells
- Osteoblastic alkaline phosphatase mRNA is stabilized by binding to vimentin intermediary filaments
- Proteolysis
- Mirolase, a novel subtilisin-like serine protease from the periodontopathogen Tannerella forsythia
- Cathepsin B-deficient mice as source of monoclonal anti-cathepsin B antibodies